Skip to main content
SpringerLink
Log in

Komplementäre Therapieverfahren

  • Chapter
Uroonkologie

  • 394 Accesses

Auszug

Gemäß einer Definition des “National Center for Complementary and Alternative Medicine„ der National Institutes of Health (NIH) in den USA handelt es sich bei alternativmedizinischen Therapieverfahren um Maßnahmen, die anstelle der konventionellen Therapie durchgeführt werden. Demgegenüber werden komplementärmedizinische Therapien ergänzend zur konventionellen Therapie angewendet (http://nccam.nih.gov/).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Kap. 9.1

  • Allensbach Umfrage 7016: Naturheilmittel 2002. Insititut für Demosko-pie Allensbach, Januar 2002

    Google Scholar 

  • Allensbach Umfrage: “Integrative Medizin und Traditionelle Chinesi-sche Medizin Ergebnisse einer repräsentativen Bevölkerungs-umfrage zur Bekanntheit und Bedeutung„. Institut für Demosko-pie Allensbach, August 2005

    Google Scholar 

  • Eisenberg DM, Davis RB, Ettner SL et al. (1998) Trends in alternative medicine use in the United States, 19901997: results of a follow-up national survey. JAMA 280: 1569–1575

    Article  PubMed  CAS  Google Scholar 

  • Fair W (1999) Back to the Future The Role of Complementary Medicine in Urology. 162: 411–420

    CAS  Google Scholar 

  • Nam RK, Fleshner N, Rukovitch E et al. (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients and epidemiological analysis. J Urol 161: 1521–1524

    Article  PubMed  CAS  Google Scholar 

  • Spahn G, Harmaring A, Lüdtke R et al. (2003) Characteristics of German Cancer Patients using CAM: a Survey in 441 Cancer Patients. FACT (8): 540

    Google Scholar 

  • Yip I, Duran N (2001) The Role of Complementary Medicine in the Treatment of Prostate Cancer. Current Urol Rep 2: 231–236

    Article  CAS  Google Scholar 

Literatur zu Kap. 9.2

  • Adlercreutz H, Honjo H, Higashi A et al. (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342: 1209–1210

    Article  PubMed  CAS  Google Scholar 

  • Ahmed S, Johnson CS, Rueger RM, Trump DL (2002) Calcitriol (1,25-dihydroxycholecalciferol) potentiates activitiy of mitoxantrone/dexamethasone in an androgen independent prostate cancer model. J Urol 168: 756–761

    Article  PubMed  CAS  Google Scholar 

  • Bagnardi V, Blangiardo M, La Vecchia C et al. (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85: 1700–1705

    Article  PubMed  CAS  Google Scholar 

  • Berndt SI, Carter BH, Landis PD et al. (2005) Prediagnostic plasma vita-min C levels and the subsequent risk of prostate cancer. Nutrition 21: 686–690

    Article  PubMed  CAS  Google Scholar 

  • Block, G (1991) Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 53(1 Suppl): 270S–282S

    PubMed  CAS  Google Scholar 

  • Boileau TW, Liao Z, Kim S et al. (2003) Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst. 95(21): 1578–86

    PubMed  CAS  Google Scholar 

  • Brooks JD, Metter, EJ, Chan DW et al. (2001) Plasma Selenium Level Before Diagnosis and the Risk of Prostate Cancer Development. J Urol 166: 2034–2038

    Article  PubMed  CAS  Google Scholar 

  • Caffrey PB, Renkel GD (1992) Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells. Cancer Res 52: 4812–4816

    PubMed  CAS  Google Scholar 

  • Cameron E, Pauling l (1978) Experimental studies designed to evaluate the management of patients with incurable cancer. Proc Natl Acad Sci USA 75(12): 62–52

    Article  Google Scholar 

  • Cha MC, Lin A, Heckling KA (2005) Low dose hexaenoic acid protects normal colonic epithelial cells from araC toxicity. BMC Pharmacol 1: 7

    Article  CAS  Google Scholar 

  • Chang-Claude J, Frentzel-Beyme R, Eilber U (1992) Mortality pattern of German vegetarians after 11 years follow-up. Epidemiology 3: 395–401

    Article  PubMed  CAS  Google Scholar 

  • Chen L, Stacewicz-Sapuntzakis M, Duncan C et al. (2001) Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 93: 1872–187

    Article  PubMed  CAS  Google Scholar 

  • Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF (2000) The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1al-pha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res 6(3): 901–908

    PubMed  CAS  Google Scholar 

  • Chen TC, Wang L, Whitlatch LW et al. (2003) Prostatic 25-hydroxyvita-min D-1alphahydroxylase and its implication in prostate cancer. J Cell Biochem 88: 315–322

    Article  PubMed  CAS  Google Scholar 

  • Clark LC, Combs GF, Turnbull BW et al (1996) Effects of selenium sup-plementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957

    Article  PubMed  CAS  Google Scholar 

  • Clinton SK, Emenhiser C, Schwartz SJ et al. (1996) cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 5(10): 823–33

    PubMed  CAS  Google Scholar 

  • Cohen LA, Zhao Z, Pittman B et al. (2003) Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors. Prostate 54: 169–178

    Article  PubMed  CAS  Google Scholar 

  • Corcoran NM, Najdovska M, Costello AJ (2004) Inorganic selenium retards progression of experimental hormone refractory prostate ancer. J Urol 171: 907–910

    Article  PubMed  CAS  Google Scholar 

  • Corder EH, Guess HA, Hulka BS et al. (1993), Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2: 467–472

    PubMed  CAS  Google Scholar 

  • De Lorgeril M, Salen P, Marin JL et al. (1998) Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med 158(11): 1181–1187

    Article  PubMed  Google Scholar 

  • Dong Y, Lee, SO, Zhang H et al. (2004) Prostate Specific Antigen Ex-pression is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling. Canc Res 64: 19–22

    Article  CAS  Google Scholar 

  • Eichholzer M (2000) Ernährung und Krebs. Ther Umschau 57(3): 146–151

    Article  CAS  Google Scholar 

  • Evans BA, Griffiths K, Morton MS (1995) Inhibition of 5-alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 147: 295–302

    PubMed  CAS  Google Scholar 

  • Fain O, Mathieu E, Thomas M (1998) Scurvy in patients with cancer. BMJ.316(7145): 1661–2

    PubMed  CAS  Google Scholar 

  • Fair WR, Fleshner NE, Heston W (1997) Cancer of the prostate: a nutriti-onal disease. Urology 50: 840–848

    Article  PubMed  CAS  Google Scholar 

  • Fearon KC, Meyenfeldt MF, Moses AG et al. (2003) Effect of a protein and energy dense N3 fatty acid enriches oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10): 1479–1486

    Article  PubMed  CAS  Google Scholar 

  • Fleischhauer AT, Arab L (2001) Garlic and cancer: A critical review of the epidemiologic literature. J Nutr 131: 1032–1040

    Google Scholar 

  • Fujioka t, Hasegawa M, Ishikura K et al. (1998) Inhibiton of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma. J Urol 160: 247–251

    Article  PubMed  CAS  Google Scholar 

  • Gianduzzo TR, Holmes EG, Tinggi U et al. (2003) Prostatic and periphe-ral blood selenium levels after oral supplementation. J Urol 170: 870–873

    Article  PubMed  CAS  Google Scholar 

  • Giovannucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst. 91(4): 317–31

    Article  PubMed  CAS  Google Scholar 

  • Giovannucci E (2005) The epidemiology of vitamin D and cancer in-cidence and mortality: A review (United States). Cancer Causes Control. 16(2): 83–95

    Article  PubMed  Google Scholar 

  • Goodman GE, Schaffer S, Omenn GS et al. (2003) The association bet-ween lung and prostate cancer risk, and serum micronutrients: re-sults and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 12: 518–526

    PubMed  CAS  Google Scholar 

  • Gosh J (2004) Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophy Res Com 315: 624–635

    Article  CAS  Google Scholar 

  • Grant WB (2002) An estimate of premature cancer mortality in the US due to inadequate radiation of solar ultraviolet-B radiation. Cancer 94: 1867–1875

    Article  PubMed  Google Scholar 

  • Hall AK (1996) Liarozole amplifies retinoid-induced apoptosis in hu-man prostate cancer cells. Anticancer Drugs. 7(3): 312–20

    Article  PubMed  CAS  Google Scholar 

  • Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Cancer 70: 2861–2869

    Article  PubMed  CAS  Google Scholar 

  • Heinonen OP, Albanes D, Virtamo J et al. (1998) Prostate cancer and sup-plementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90: 440–446

    Article  PubMed  CAS  Google Scholar 

  • Hennekens CH, Buring JE, Manson JE et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 334(18): 1145–1149

    Article  PubMed  CAS  Google Scholar 

  • Hercberg S, Galan P, Preziosi P et al. (2004) The SU.VI.MAX Study: a randomized, placebo-xontrolled trial of the health effects of antio-xidnt vitamins and minerals. Arch Intern Med 164: 2335–2342

    Article  PubMed  CAS  Google Scholar 

  • Hershberger PA, Yu WD, Medzelewski RA et al (2001) Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accerlaters paclitaxel-induced apoptosis. Clin Cancer Res 7: 1043–1051

    PubMed  CAS  Google Scholar 

  • Hirayama T (1985) A large scale cohort study on cancer risks by diet with special reference to the risk reducing effects of green-yellow vegetable consumption. Princess Takamatsu Symp. 116: 41–53

    Google Scholar 

  • Jacobsen BK, Knutsen SF, Fraser GE (1998) Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9: 553–557

    Article  PubMed  CAS  Google Scholar 

  • Jamison JM Gilloteaux J, Taper HS et al. (2001) Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer. J Nutr. 131(1): 158S–160S

    PubMed  CAS  Google Scholar 

  • Khaw K, Bingham S, Luben R et al. (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Nor-folk prospective study: a prospective population study. Euroean Prospective Investigation into Cancer and Nutrition. Lancet 357(9257): 657–663

    Article  PubMed  CAS  Google Scholar 

  • Kim DJ, Gallagher RP, Hislop TG et al. (2000) Premorbid diet in relation to survival from prostate cancer (Canada). Cancer Causes Control 11: 65–77

    Article  PubMed  CAS  Google Scholar 

  • Klein E, Lippman S, Thompson I et al. (2003) The Selenium an Vitamin E Cancer Prevention Trial. World J Urol 21: 21–27

    PubMed  CAS  Google Scholar 

  • Koerber K, Männle T, Leitzmann C (2004) Vollwert-Ernährung, 10. Auf-lage, Haug-Verlag, Stuttgart

    Google Scholar 

  • Kokron O, Alth G, Cerni C et al. (1982) Ergebnisse einer vergleichenden Therapiestudie beim inoperablen Bronchuskarzinom. Onkologie 5: 20–22

    PubMed  CAS  Google Scholar 

  • Kyle E, Neckers L, Takimoto C et al. (1997) Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 51: 193–200

    PubMed  CAS  Google Scholar 

  • Landström M, Zhang JX, Hallmans G et al (1998) Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36: 151–161

    Article  PubMed  Google Scholar 

  • Leitzmann C (1995) Ernährung und Krebs. In: Wrba (Hrsg) Kombinierte Tumortherapie. Hippokrates-Verlag Stuttgart

    Google Scholar 

  • Leitzmann C, Müller C, Michel P et al. (2003) Ernährung in Prävention und Therapie, 2. Auflage, Hippokrates, Stuttgart

    Google Scholar 

  • Levy J, Bosin D, Feldman B et al. (1995) Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-ca-rotene or beta-carotene. Nutr Cancer. 24(3): 257–66

    PubMed  CAS  Google Scholar 

  • Lokeshwar B. L., Schwartz G. G., Selzer M. G., Burnstein K. L., Zhuang S-H., Block N. L., Binderup L. (1999) Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (cal-citriol) and EB 1089. Cancer Epidemiol Biomark Prev, 8: 241–248

    CAS  Google Scholar 

  • Lowe GM, Booth LA, Young AJ et al. (1999) Lycopene and ß-carotene protect against oxidative damage in HT29 cells at low concentra-tions but rapidly lose this capacity at higher doses. Free Radic Res 30: 141–151

    Article  PubMed  CAS  Google Scholar 

  • Mayland CR, Bennett MI, Allan K (2005) Vitamin C deficiency in cancer patients. Palliat Med. 19(1): 17–20

    Article  PubMed  Google Scholar 

  • Meyer F. Bairati I, Shadmani R et al. (1999) Dietary fat and prostate cancer survival. Cancer Causes Control 10: 245–251

    Article  PubMed  CAS  Google Scholar 

  • Moertel C, Fleming T et al. (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 312(3): 137–141

    Article  PubMed  CAS  Google Scholar 

  • Mousavi Y, Adlercreutz H (1993) Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 58: 301–304

    Article  PubMed  CAS  Google Scholar 

  • Moyad, M (2003) The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following defi-nitive therapy: Part I. Lifestyle changes. Curr Opin Urol 13(2): 137–145

    Article  PubMed  Google Scholar 

  • Nelson PS, Montgomery B (2003) Unconventional therapy for prostatecancer: Good, bad or questionable? Nature Rev (3): 845–858

    Article  CAS  Google Scholar 

  • Nesby-O DellS, Scanlon KS, Cogswell ME et al. (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 19881994. Am J Clin Nutr 76: 187–192

    Google Scholar 

  • Omenn GS, Goodman GE, Thromquist MD et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88(21): 1550–1559

    Article  PubMed  CAS  Google Scholar 

  • Peehl D. M., Skowronski R. J., Leung G. K., Wong S. T., Stamey T. A., Feldman D. Antiproliferative effects of 1,25-dihydroxyvitamin D 3 on primary cultures of human prostatic cells. Cancer Res., 54: 805–810, 1994

    PubMed  Google Scholar 

  • Riordan NH, Riordan HD, Meng X et al. (1995) Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses. 44(3): 207–13

    Article  PubMed  CAS  Google Scholar 

  • Santibanez JF, Navarro A, Martinez J (1997) Genistein inhibits prolifera-tion and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 17: 1199–1204

    PubMed  CAS  Google Scholar 

  • Scheef W (1995) In: Wrba (Hrsg) Kombinierte Tumortherapie, Hippo-krates Verlag, Stuttgart

    Google Scholar 

  • Schumacher K, (2000) Therapie maligner Tumoren, Schattauer-Verlag

    Google Scholar 

  • Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? Anticancer Res 10: 1307–1312

    PubMed  CAS  Google Scholar 

  • Schwartz GG., Oeler T. A., Uskokovic M. R., Bahnson R. R. (1994) Human prostate cancer cell lines: inhibition of proliferation by vitamin D analogs. Anticancer Res., 14: 1077–1081,. Cancer Causes Control 16: 8395

    PubMed  CAS  Google Scholar 

  • Schwartz GG., Wang M-H., Zhang M., Singh R. J., Siegal G. P. (1997) 1a,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomark. Prev., 6: 727–732

    CAS  Google Scholar 

  • Sverson KJ, Noura AMY, Grove JS et al. (1989) A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857–1860

    Google Scholar 

  • The a-Tocopheraol ß-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and ß-Carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029–1035

    Article  Google Scholar 

  • Virtamo J, Pientinen P, Huttunen JK et al. (2003) ATBC Study Group.Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290: 476–485

    Article  PubMed  CAS  Google Scholar 

  • Weiger W, Smith M, Pharm M et al. (2002) Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer. Ann Inern Med 137: 889–903

    Google Scholar 

  • Willett WC, Polk BF, Morris JS et al. (1983) Prediagnostic serum sele-nium and risk of cancer. Lancet 2(8243): 130134

    Google Scholar 

  • Willis MS, Wians FH (2003) The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta. 330(12): 57–83

    Article  PubMed  CAS  Google Scholar 

  • Wirth M, Hakenberg O (2005) Prävention des Prostatakarzinoms. Dtsch Med Wochenschr 130(36): 2002–2004

    Article  PubMed  CAS  Google Scholar 

  • Woo, TC, Choo, R, Jamieson M et al. (2005) Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy. Nutrition Cancer 51(1): 32–36

    Article  CAS  Google Scholar 

  • Yoshizawa K, Willett WC, Morris SJ et al. (1998) Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate Cancer. J Natl Cancer Inst 90: 1219–1224

    Article  PubMed  CAS  Google Scholar 

  • Zeegers MP, Goldbohm RA, van den Brandt PA (2001) Are retinol, vit-amin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study. Br J Cancer. 2001 Sep 28; 85(7): 977–83

    Article  PubMed  CAS  Google Scholar 

  • Zeegers MP, Goldbohm RA, Bode P et al. (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 11: 1292–1297

    PubMed  CAS  Google Scholar 

  • Zhang Y, Ni J, Messing E et al. (2002) Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. PNAS 11: 7408–7413

    Article  CAS  Google Scholar 

  • Zittermann A, Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89(5): 552–72, 2003

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kap. 9.3

  • Adams J, White M.: Are activity promotion interventions based on the transtheoretical model effective? A critical review. Br J Sports Med. 2003 Apr; 37(2): 10614. Review

    Google Scholar 

  • Atlantis E, Chow CM, Kirby A, Singh MF.: An effective exercise-based in-tervention for improving mental health and quality of life measu-res: a randomized controlled trial. Prev Med. 2004 Aug; 39(2): 424–34

    Google Scholar 

  • Benson, H: The Relaxation Response. New York: Avon Books, 1976

    Google Scholar 

  • Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ.: A meta-ana-lysis of exercise interventions among people treated for cancer. Support Care Cancer. 2006 Jan 31

    Google Scholar 

  • Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, Urbanowski F, Harrington A, Bonus K, Sheridan JF.: Al-terations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003 Jul-Aug; 65(4): 564–70

    Google Scholar 

  • Dobos G, Altner N, Lange S, Michalsen A, Musial F, Paul A: Mind/Body Medicine als Bestandteil der Integrativen Medizin. In: Bundesge-sundheitsblatt, 2006. (in Vorbereitung)

    Google Scholar 

  • Dusek JA, Chang BH, Zaki J, Lazar S, Deykin A, Stefano GB, Wohlhueter AL, Hibberd PL, Benson H.: Association between oxygen consump-tion and nitric oxide production during the relaxation response. Med Sci Monit. 2006 Jan; 12(1): CR1–10. Epub 2005 Dec 19

    Google Scholar 

  • Giovannucci EL, Lin, Y, Leitzmann MF, Stampfer MJ, Willett WC. A pro-spective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 2005, 165(9), 1005–1010

    Article  PubMed  Google Scholar 

  • Hoffman JW, Benson H, Arns PA, Stainbrook GL, Landsberg GL, Young JB, Gill A.: Reduced sympathetic nervous system responsivity associated with the relaxation response. Science. 1982 Jan 8; 215(4529): 190–2

    Google Scholar 

  • Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCor-mac P, Raisin CJ, Ornish D. A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial. Cancer Nurs. 2005 Mar-Apr; 28(2): 99–107

    Google Scholar 

  • Krupski TL, Kwan L, Fink A, Sonn GA, Maliski S, Litwin MS. Spirituality in-fluences health related quality of life in men with prostate cancer. Psychooncology. 2006 Feb; 15(2): 121–31

    Google Scholar 

  • NIH, National Center for Complementary and Alternative Medicine, http://nccam.nih.gov/health/backgrounds/mindbody.htm, Zu-griff 12.1.06

  • Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ.: Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998 Dec 16; 280(23): 2001–7

    Google Scholar 

  • Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCor-mac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR.: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005 Sep; 174(3): 1065–9; discussion 106970

    Google Scholar 

  • Prochaska JO, DiClemente CC.: Stages of change in the modification of problem behaviors. Prog Behav Modif. 1992; 28: 183–218. Review

    PubMed  CAS  Google Scholar 

  • Saxe, G., Hebert, J., Carmody, J., Kabat-Zinn, J., Rosenzweig, P., Jar-zobski, D., Reed, G., and Blute, R.: Can Diet, in conjunction with Stress Reduction, affect the Rate of Increase in Prostate-specific Antigen After Biochemical Recurrence of Prostate Cancer? J. of Urology 66/2001: 2202–2207

    Google Scholar 

  • Spahn G, Lehmann N, Franken U, Paul A, Langhorst J, Michalsen A, Dobos GJ Improvement of fatigue and role function of cancer patients after an outpatient integrative mind/body intervention. FACT 2003, 8, 540

    Google Scholar 

  • Spiegel D.: Mind matters group therapy and survival in breast cancer. N Engl J Med. 2001 Dec 13; 345(24): 1767–8

    Google Scholar 

  • Woll, A, Bös, K: Wirkungen von Gesundheitssport. In: Bewegungsthera-pie und Gesundheitssport 2004; 20: 97–106

    Article  Google Scholar 

Literatur zu Kap. 9.4

  • Baier JE, Neumann HA, Gallati H, Ricken D (1991) Improvement of im-paired mitogen-induced Interferon-gamma release of peripheral blood mononuclear Cells derived from tumor patients by Factor AF2 Res Exp Med 191: 281–289

    Article  CAS  Google Scholar 

  • Bantel E, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S (1999) Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apop-tosis. Cancer Res 59: 2083–2090

    PubMed  CAS  Google Scholar 

  • Beuth J, Schierholz JM, Ko HL et al. (2001) Application-dependent im-munomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice. In Vivo 15(5): 403–406

    PubMed  CAS  Google Scholar 

  • Beuth J, Schierholz JM, Mayer G (1999) Immunomodulating and anti-metastatic activity of thymic peptides in BALB/c mice. Anticancer Res 19(4B): 2993–2995

    PubMed  CAS  Google Scholar 

  • Bodey B, Bodey B Jr, Siegel SE et al. (2000) Review of thymic hormones in cancer diagnosis and treatment. Int J Immunopharmacol 22(4): 261–273

    Article  PubMed  CAS  Google Scholar 

  • Burger AM, Mengs U, Schüler JB, Zinke H, Lentzen H, Fiebig HH (1999) Recombinant misteltoe lectin (ML) is a potent inhibitor of tumor cell growth in vitro and in vivo. Proceedings of the American As-sociation for Cancer research 40: 399–399

    Google Scholar 

  • Burger AM, Mengs U, Schuler JB, Fiebig HH (2001a) Anticancer activity of an aqueous mistletoe extract (AME) in syngenic murine tumor models. Anticancer Res 21: 1965–1968

    PubMed  CAS  Google Scholar 

  • Burger AM, Mengs U, Schüler JB, Fiebig HH (2001b) Antiproliferative activity of an aquaeous mistletoe extract in human tumor cell lines and xenografts in vitro. Arzneim Forsch 51: 748–757

    CAS  Google Scholar 

  • Cramer R, Dri P, Spessotto P, Mittenzwei H, Patriarca P (1993) Potenti-ation of human polymorphonuclear leukocytes respiratory burst and phagoxytosis by a standardized liver and spleen fraction of peptides. Drug Res 43: 686–689

    CAS  Google Scholar 

  • Goebell PJ, Otto T, Suhr J, Rübben H (2002) Evaluation of an uncon-ventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomised phase II trial. J Urol 168: 72–75

    Article  PubMed  Google Scholar 

  • Ivanov VI, Turdyev AA, Aleksandrova IA, Svidovaya LV, Rodina EA (1987) Liver microso-mal lipids of mice irradiated and administered an extract turtle spleen. Radiobiologiia 27: 257–264

    PubMed  CAS  Google Scholar 

  • Kindler M (1997) Factor AF2 als Begleitmaßnahme zur Chemotherapie myeloprotektive und antiemetische Wirkung. J Oncol 29: 7–10

    Google Scholar 

  • Klein AS, Shoham J (1981) Effect of the thymic facot, thymostimulin (TP-1), on the survival rate of tumor-bearing mice. Cancer Res 41(8): 3217–3221

    PubMed  CAS  Google Scholar 

  • Kouttab NM, Prada M, Cazzola P (1989) Thymomodulin: biological pro-perties and clinical applications. Med Oncol Tumor Pharmacother 6(1): 5–9

    PubMed  CAS  Google Scholar 

  • Krege S, Hinke A, Otto T, Rübben H (2002) Bewertung des Kom-plementärtherapeutikums Factor AF2 als Supportivum in der Behandlung des Fortgeschrittenen Urothelkarzinoms Urologe A 41: 164–168

    Google Scholar 

  • Lange OF (1987) Supportive Therapie mit xenogenen Peptiden bei Patienten mit metastasiertem Mammakarzinom unter aggressi-ver Chemotherapie (modifiziertes AC-Schema), eine prospektive rando-misierte Doppelblindstudie. Onkologie 10(Suppl): 40–43

    PubMed  CAS  Google Scholar 

  • Leder GH, Leder O (1990) Morpholigical studies on the subchronic toxicity of a standardized liver-and spleen-extract. Drug Res 40: 187–189

    CAS  Google Scholar 

  • Leder GH, Fiebig HH, Widmer KH, Arnold H (1986) Colony inhibition of human tumor xenografts in vitro by Factor AF2. J Cancer Res Clin Oncol 111: 49

    Article  Google Scholar 

  • Mengs U, Schwarz T, Bulitta M, Weber K (2000) Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. Anticancer Res 20: 3565–3568

    PubMed  CAS  Google Scholar 

  • Papadopulos I, Wand H (1989) Prüfung der Wirksamkeit von Factor AF2 auf die verbesserte Verträglichkeit des PE-Schemas (Epirubicin/ Cisplatin) beim metastasierten Prostatakarzinom. Onkologie 12: 26–31

    Google Scholar 

  • Ribéreau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R (1996) Mistletoe lectins I, II and III induce the production of cytoki-nes by cultured human monocytes. Cancer Lett 109: 33–38

    Article  PubMed  Google Scholar 

  • Stirpe F, Legg RF, Onyon LJ, Ziska P, Franz H (1980) Inhibition of protein synthesis by a toxic lextin from Viscum album L. (mistletoe). Bio-chem J 190: 843–845

    CAS  Google Scholar 

  • Stoll, G (2003) Immunologisch active Signalpeptice in der Komplemen-täronkologie-Abgrenzung, Wirkmechanismen, klinische Studien. Z Onkol 35(1): 37–50

    Article  Google Scholar 

  • Urech K, Buessing A, Thalmann G, Schaefermeyer H, Heusser P (2006) Antiproliferative effects of mistletoe (Viscum album L) extract in urinary bladder carcinoma cell lines. Anticancer Res 26: 3049–3056

    PubMed  Google Scholar 

  • Wagner H, Röllinghoff M (1973) Cell-mediated immunity in vitro against syngeneic mouse plasma tumor cells. Nature 291: 53–54

    Google Scholar 

  • Yagi, M, Yamashita T, Tsubura E (1985) Effect of a thymic factor, thy-mostimulin, on growth and pulmonary metastases of Lewis lung carcinoma. Cancer Immunol Immunother 19(3): 198–204

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kap. 9.5

  • Beuth J, Ost B, Pakdaman A, et al (2001) Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients results of an epidemiological multi-centre retrolective cohort study. Cancer Chemother Pharmacol 47(Suppl): S45–S54

    Article  PubMed  CAS  Google Scholar 

  • Desser L, Holomanova D, Zavadova E et al. (2001) Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in hu-man blood. Cancer Chemother Pharmacol. 47(Suppl): S10–S15

    Article  PubMed  CAS  Google Scholar 

  • Gujral M, Patnaik P, Kaul R et al. (2001) Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol 47(Suppl): S23–S28

    Article  PubMed  CAS  Google Scholar 

  • Harrach T, Gebauer F, Eckert K et al. (1994) Bromelain proteases mo-dulate the CD44 expression on human MOLT 4/8 leukaemia and SK-Mel 28 melanoma cells in vitro. Int J Onco 5: 485

    CAS  Google Scholar 

  • Lauer D, Müller R, Cott D et al. (2001) Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy Cancer Chemother Pharmacol. 47Suppl: S4–9

    Article  PubMed  CAS  Google Scholar 

  • Lehmann P (1997) Immunomodulation by proteolytic enzymes. Ne-phrol Dial Transplant 11: 953

    Google Scholar 

  • Sakalova A, Bock P, Dedik L et al. (2001) Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemother Pharmacol. 47(Suppl): S38–S44

    Article  PubMed  CAS  Google Scholar 

  • Schedler M, Lind A, Schatzle W et al. (1990) Adjuvant therapy with hy-drolytic enzymes in oncology: a hopeful effort to avoid bleomycin induced pneumotoxicity? J Cancer Res Clin Oncol 116: 697

    Google Scholar 

  • Stauder G, Beaufort F, Steichhan P (1991) Strahlentherapeutische Ne-benwirkungen bei Abdominalkrebspatienten und deren Reduk-tion durch hydrolytische Enzympräparate. Dtsch Zschr Onkol 23: 7

    Google Scholar 

  • Wald M, Olejar T, Sebkova V et al. (2001) Mixture of trypsin, chymotryp-sin and papain reduces formation of metastases and extends sur-vival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother Pharmacol. 47(Suppl): S16–S22

    Article  PubMed  CAS  Google Scholar 

  • Wolf M, Ransberger K (1968) Wirkung proteolytischer Enzyme auf die gegenseitige Wachstumsbeeinflussung von normalen und Tumorgeweben. Arch Geschwulstforsch 31: 317–331

    PubMed  CAS  Google Scholar 

  • Wrba H (1995) Krebstherapie mit proteolytischen Enymen. In: Kom-binierte Tumortherapie, Hippokrates Verlag, Stuttgart, 2. Auflage 1995

    Google Scholar 

Literatur zu Kap. 9.6

  • Bent S, Kane C, Shinohara K et al. (2006) Saw Palmetto for Benign Pro-static Hyperplasia. NEJM 354: 557–566 London

    Article  PubMed  CAS  Google Scholar 

  • Cassileth BR, Lucarelli CD (2003) Herb-drug interactions in oncology. BC Decker Inc, Hamilton, London

    Google Scholar 

  • Chan JM, Elkin EP, Silva SJ et al. (2005) Total and specific complemen-tary and alternative medicine use in a large cohort of men with prostate cancer. Urology 66(6): 1223–1228

    Article  PubMed  CAS  Google Scholar 

  • Currier NL, Miller SC (2001) Echinacea purpurea and melatonin aug-ment natural-killer cells in leukemic mice and prolong life span. J Altern Complement Med 7(3): 241–251

    Article  PubMed  CAS  Google Scholar 

  • Eng J, Ramsum D, Verhoef M et al. (2003) A population-based survey of complementary and alternative medicine use in men recently dia-gnosed with porstate cancer. Integr Cancer Ther 2(3): 212–216

    Article  PubMed  Google Scholar 

  • Ferguson PJ, Kurowska E, Freeman DJ et al. (2004) A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134(6): 1592–1535

    Google Scholar 

  • Goldmann WH, Sharma AL, Currier SJ et al. (2001) Saw palmetto berry extract inhibits cell growth and Cox-2 expression in postatic can-cer cells. Cell Biol Int 25(11): 1117–1124

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, von Moltke LL, Perloff ES et al. (2006) Interaction of flur-biprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther. 79(1): 125–33

    Article  PubMed  CAS  Google Scholar 

  • Habib FK, Ross M, Ho CK et al. (2005) Serenoa repens (Permixon) inhi-bits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer 114(2): 190–194

    Article  PubMed  CAS  Google Scholar 

  • Hill B, Kyprianou N (2004) Effect of permixon on human prostate cell growth: lack of apoptotic action. Prostate 61(1): 73–80

    Article  PubMed  CAS  Google Scholar 

  • Iguchi K, Okumura N, Usui S et al. (2001) Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apopto-sis and necrosis in human postatic LNCaP cells. Prostate 47(1): 59–65

    Article  PubMed  CAS  Google Scholar 

  • Jepson RG, Mihaljevic L, Craig J (2000) Cranberries for treating urinary tract infections. Cochrane Database Syst Rev. 2000 (2): CD 001322

    Google Scholar 

  • Jepson RG, Mihaljevic L, Craig J (2004) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2004 (2): CD 001321

    Google Scholar 

  • Kim HS, Lee EH, Ko SR et al. (2004) Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27(4): 429–435

    Article  PubMed  CAS  Google Scholar 

  • Lee TK, Johnke RM, Allison RR, et al (2005) Radioprotective potential of ginseng. Mutagenesis 20(4): 237–243

    Article  PubMed  CAS  Google Scholar 

  • Lersch C, Zeuner M, Bauer A et al. (1990) Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), Echinacea purpurea extracts (Echinacin) and thymostimulin. Arch Geschwulstforsch 60(5): 379–383

    PubMed  CAS  Google Scholar 

  • Lersch C, Zeuner M, Bauer A et al. (1992) Nonspecific immunostimula-tion with low doses of cyclophosphamide (LDCY) in patients with far advanced colorectal cancers: preliminary results. Cancer Invest 10(5): 343–348

    Article  PubMed  CAS  Google Scholar 

  • Linde K, Mulrow CD (2000) St Johns wort for depression. Cochrane Database Syst Rev 2000 (2): CD000448

    Google Scholar 

  • Linde K, Barrett B, Wölkart K et al. (2005) Echinacea for preventing and treating the common cold. The Cochrane Database of Systematic Reviews (Issue 2006/1)

    Google Scholar 

  • Linde K, Mulrow CD, Berner M et al. (2005) St Johns wort for depres-sion. Cochrane Database Syst Rev 2005 (2): CD000448

    Google Scholar 

  • Liu WK, Xu SX, Che CT (2000) Anti-proliferative effect of ginseng sapo-nins on human prostate cancer cell line

    Google Scholar 

  • Melchart D, Clemm C, Weber B et al. (2002) Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract un-desired effects of chemotherapy-a pilot study. Phytother Res 16(2): 138–142

    Article  PubMed  CAS  Google Scholar 

  • Mörike K, Gleiter DH (2003) Pflanzliche Arzneimittel. Internist 44: 748–752

    PubMed  Google Scholar 

  • Murphy BT, MacKinnon SL, Yan X et al. (2003) Identification of triter-pene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 51(12): 3541–5

    Article  PubMed  CAS  Google Scholar 

  • Seeram NP, Adams LS, Hardy ML et al. (2004) Total cranberry extract versus its phytochemical constituents: antiproliferative and syner-gistic effects against human tumor cell lines. J Agric Food Chem. 52(9): 2512–7

    Article  PubMed  CAS  Google Scholar 

  • Shin HR, Kim JY, Yun TK et al. (2000) The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 11(6): 565–576

    Article  PubMed  CAS  Google Scholar 

  • Sparreboom A, Cox MC, Acharya MR et al. (2004) Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. J Clin Oncol 22(12): 2489–2503

    Article  PubMed  CAS  Google Scholar 

  • Vogler BK, Pittler MH, Ernst E (1999) The efficacy of ginseng. Asyste-matic review of randomised clinical trials. Eur J Clin Pharmacol 55(8): 567–575

    Article  PubMed  CAS  Google Scholar 

  • Wilt T, Ishani A, Mac Donald R (2002) Serenoa repens for benign postatic hyperplasia. Cochrane Database Syst Rev 2002 (3)

    Google Scholar 

  • Yun TK (2003) Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523-524: 63–74

    PubMed  Google Scholar 

Literatur zu Kap. 9.7

  • Balzarini, A., Felisi, E.; Martini, A.; Conno, F. de (2000) Efficacy of ho-meopathic treatment of skin reactions during radiotherapy for breast cancer, A randomised, double-blind clinical trial. Brit Hom J 89(1): 8–12

    Article  CAS  Google Scholar 

  • Linde K, Clausius N, Ramirez G et al. (1997) Are the clinical effects of ho-meopathy placebo effects ? A meta-analysis of placebo-controlled trials. Lancet 350: 834–843

    Article  PubMed  CAS  Google Scholar 

  • Oberbaum, M., Yaniv, I.; Ben-Gal, Y.; Stein, J.; Ben-Zvi, N.; Freedman, L.S.; Branski, D. (2001) A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation, Cancer 92(3): 684–690

    Article  PubMed  CAS  Google Scholar 

  • Thompson EA, Reilly D (2002) The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliative Med 16: 227–233

    Article  CAS  Google Scholar 

Literatur zu Kap. 9.8

  • Badtke G, Mudra I: Neuraltherapie, Lehrbuch und Atlas, Ullstein Medi-cal, Wiesbaden 1998

    Google Scholar 

  • Barop H.: Lehrbuch und Atlas Neuraltherapie nach Huneke, Hippokra-tes, Stuttgart 1996

    Google Scholar 

  • Dosch M: Bildatlas der Neuraltherapie, Haug, Heidelberg 1994 Dosch P: Lehrbuch der Neuraltherapie nach Huneke, Haug, Heidelberg 1995

    Google Scholar 

  • Fischer L: Neuraltherapie nach Huneke, Hippokrates, Stuttgart 1998

    Google Scholar 

  • Villar-Garea A, Fraga MF, Espada J, et al (2003) Procaine is a DNA-deme-thylating agent with growth-inhibitory effects in human cancer cells. Cancer Res. 63(16): 4984–4989

    PubMed  CAS  Google Scholar 

Literatur zu Kap. 9.9

  • Alimi D, Rubino C, Pichard-Léandri E et al. (2003) Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 21(22): 4120–4126

    Article  PubMed  Google Scholar 

  • Ezzo J, Vickers A, Richardson A et al. (2005) Acupuncture-Point Stimu-lation for Chemotherapy-Induced Nausea and Vomiting. J Clin Oncol 28: 7188–7198

    Article  Google Scholar 

  • Heine H (1988) Funktionelle Morphologie der Akupunkturpunkte. Akupunktur-Theorie und Praxis 1: 4.

    Google Scholar 

  • Kou W, Bell JD, Gareus I et al. (2005) Repeated acupuncture treatment affects leucocyte circulation in healthy young male subjects: a randomized single-blind two-period crossover study. Brain Behav Immune 19(4): 318–324

    Article  Google Scholar 

  • Melchart D, Streng A, Hoppe A et al. (2006) Akupunktur bei chro-nischen Schmerzen: Ergebnisse aus dem Modellvorhaben der Ersatzkassen. Dtsch Arztebl 2006; 103(4): A 187–95

    Google Scholar 

  • Spahn G (2005) Komplementäre Tumorschmerztherapie welche Kon-zepte gibt es? Der Schmerz Suppl 1: S11

    Google Scholar 

  • Vickers A, Straus D, Fearon B et al. (2004) Acupuncture for Postchemo-therapy Fatigue: A Phase II Study. J Clin Oncol 22(9): 1731–1735

    Article  PubMed  Google Scholar 

  • Witt C, Brinkhaus B, Jena S et al. (2006) Wirksamkeit, Sicherheit und Wirtschaftlichkeit der Akupunktur Ein Modellvorhaben mit der Techniker Krankenkasse. Dtsch Arztebl 2006; 103(4): A 196–202

    Google Scholar 

  • Acupuncture NIH Consensus Statement Online 1997 Nov 35; 15(5): 1–34

    Google Scholar 

Literatur zu Kap. 9.10

  • Ames MM; Moyer TP; Kovach JS (1981) Pharmacology of amygdalin (laetrile) in cancer patients. Cancer chemother pharmacol 6(1): 51–57

    Article  PubMed  CAS  Google Scholar 

  • Berbari P, Thibodeau A, Germain L et al. (2000) Antiangiogenic effects of the oral administration of liquid cartilage extract in humans. J Surg Res 89(2): 108–113

    Article  Google Scholar 

  • Blackadar C (1993) Skeptics of oral administration of shark cartilage. J Natl Cancer Inst 85: 1961–1962

    Article  PubMed  CAS  Google Scholar 

  • Bonham M, Posakony J, Coleman I et al. (2005) Characterization of che-mical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 11(10): 3905–3914

    Article  PubMed  CAS  Google Scholar 

  • Bromley J, Hughes BG, Leong DC et al. (2005) Life-threatening inter-action between complementary medicines: cyanide toxicity fol-lowing ingestion of amygdalin and vitamin C. Ann Pharmacother 39(9): 1566–1569

    Article  PubMed  Google Scholar 

  • Chitnis MP; Adwankar MK; Amonkar AJ (1985) Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leuka-emia and P815 mast cell leukaemia. J Cancer Res Clin Oncol 109(3): 208–209

    Article  PubMed  CAS  Google Scholar 

  • Dandekar DS, Lokeshwar VB, Cevallos-Arellano E, Soloway MS, Lokesh-war BL (2003) An orally active Amazonian plant extract (BIRM) in-hibits prostate cancer growth and metastasis. Cancer Chemother Pharmacol 52: 59–66

    Article  PubMed  CAS  Google Scholar 

  • de la Taille A, Buttyan R, Hayek O, et al (2000) Herbal therapy PC-SPES: In vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 164: 1229–1234

    Article  PubMed  Google Scholar 

  • Kubota T, Hisatake J, Hisatake Y, et al (2000) PC-SPES: A unique inhi-bitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 42: 163–171

    Article  PubMed  CAS  Google Scholar 

  • Loprinzi C, Levitt R, Barton D et al. (2005) Evalutation of shark cartilage in patients with advanced cancer: a North Central Cancer Treat-ment Group trial. Cancer 104(1): 176–182

    Article  PubMed  Google Scholar 

  • Moertel CG; Fleming TR; Rubin J (1982) A clinical trial of amygdalin (La-etrile) in the treatment of human cancer. NEJM 306(4): 201–206

    PubMed  CAS  Google Scholar 

  • O’Brian B, Quigg C, Leong T (2005) Severe cyanice toxicity from “vita-min supplements„. Eur J Emerg Med 12(5): 257–258

    Article  Google Scholar 

  • Oh WK, George DJ, Hackmann K et al. (2001) Activity of the herbal combination, PC-SPES, in the treatment of patients with andro-gen-independent prostate cancer. Urology 57: 122–126

    Article  PubMed  CAS  Google Scholar 

  • Oh WK, Kantoff PW, Weinberg V et al. (2004) Prospective, Multicenter, Randomized Phase II Trial of the Herbal Supplement, PC-SPES, an Diethylstilbestrol in Patients With Androgen-Independent Pros-tate Cancer. J Clin Oncol 22(18): 3705–3712

    Article  PubMed  CAS  Google Scholar 

  • Park HJ, Yoon SH, Han LS et al. (2005) Amygdalin inhibits genes related to cell-cycle in SNU-C4 human colon cancer cells. World J Gastro-enterol 11(33): 5156–5161

    CAS  Google Scholar 

  • Sheu J, Fu C, Tsai M et al. (1998) Effect of U-995, a potent shark car-tilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities. Anticancer Res. 18: 4435–4441

    PubMed  CAS  Google Scholar 

  • Small E, Frohlich M, Bok R et al. (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18: 3595–3603

    PubMed  CAS  Google Scholar 

  • Sovak M, Seligson AL, Konas M, et al (2002) Herbal composition PC-SPES for management of prostate cancer: Identification of active principles. J Natl Cancer Inst 94: 1275–1281

    PubMed  CAS  Google Scholar 

  • Syrigos KN, Rowlinson-Busza G, Epenetos AA (1998) In vitro cytoto-xicity following specific activation of amygdalin by beta-gluco-sidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer. 78(6): 712–9

    Article  PubMed  CAS  Google Scholar 

  • Weiger W, Smith M, Pharm M et al. (2002) Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer. Ann Inern Med 137: 889–903

    Google Scholar 

  • Zur Anwendung des Präparates “Galavit„ in der Krebstherapie (2001) Arzneimittelkommission der deutschen Ärzteschaft. Dtsch Ärz-tebl 98(15): A1016

    Google Scholar 

  • Zur Anwendung des Präparates “Ukrain„ in der Krebstherapie (2001) Eine gemeinsame Stellungnahme der Arzneimittelkommission der deutschen Ärzteschaft und der deutschen Krebsgesellschaft e. V. Dtsch Ärztebl 98(7): A418–420

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kliniken Essen-Mitte Knappschafts-Krankenhaus, Am Deimelsberg 34a, 45276, Essen

    Prof. Dr. med. G. Dobos (Chefarzt der Klinik für Innere Medizin V Naturheilkunde u. Integrative Medizin) & Dr. phil. N. Altner

  2. Klinik für Innere Medizin V Naturheilkunde u. Integrative Medizin, Kliniken Essen-Mitte Knappschafts-Krankenhaus, Am Deimelsberg 34a, 45276, Essen

    Dr. med. F. Saha

  3. Klinik Susenberg, Schreberweg 9, CH-8044, Zürich

    Dr. med. G. Spahn

  4. Klinik und Poliklinik für Urologie, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    Priv.-Doz. Dr. med. S. Krege, A. Rose, Dr. med. F. vom Dorp & Prof. Dr. med. H. Rübben (Direktor der Klinik und Poliklinik für Urologie)

Authors
  1. Prof. Dr. med. G. Dobos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. F. Saha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. phil. N. Altner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. med. G. Spahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Priv.-Doz. Dr. med. S. Krege
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dr. med. F. vom Dorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Prof. Dr. med. H. Rübben
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    Herbert Rübben (Direktor der Klinik und Poliklinik für Urologie) (Direktor der Klinik und Poliklinik für Urologie)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Dobos, G. et al. (2007). Komplementäre Therapieverfahren. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33848-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33848-2_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33847-5

  • Online ISBN: 978-3-540-33848-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation